Dusa Pharmaceuticals DUSA reported its Q4 EPS at $0.12, versus the consensus of $0.04. DUSA reported its Q4 revenue at $12 million, versus the consensus of $10.28 million.
DUSA shares gained 7.02% to close at $3.20 yesterday.
Read more <a href="http://www.benzinga.com/markets/company-news">from Benzinga's Company news.</a>
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in